Advancements in cholangioscopy

SpyGlass™ DS II Direct Visualization System

Enables direct visualization imaging and therapy during ERCP to help optimize the diagnosis and treatment of biliary gallstone and biliary stricture management.

This cholangioscopy imaging system is designed to help visualize and provide access to the pancreaticobiliary system and compatible with a suite of accessories to enable the diagnosis and management of stones and strictures. Utilizing targeted biopsies in ERCPs has been shown to provide increased sensitivity and specificity in tissue diagnosis compared to conventional ERCP methods.¹ Stone removal with cholangioscopy may reduce the need for more invasive and costly procedures, which may have a significant impact on patient outcomes and patient satisfaction.²

Watch the SpyGlass DS II animation to see how the scope and accessories allow physicians to directly manage indeterminate strictures and complex stones in the bile ducts.

Clinical management

In a clinical study of 289 patients, clinical management was altered in ~85% of patients undergoing diagnostic ERCP with Cholangioscopy.³

Celebrating cholangioscopy innovation

In this episode of GI EndoCast, hear Dr. Raijman discuss his perspective on the evolution of cholangioscopy and how he incorporates it into his clinical practice.

Dr. Isaac Raijman is a paid consultant of Boston Scientific.

Review clinical evidence

PDF clinical overview of SpyGlass DS II Direct Visualization System.

Download the Clinical Application Guide to review the data that demonstrates how the SpyGlass DS II Direct Visualization System allows you to see and enable diagnosis and treatment of bile duct disease.

Filename: spyglass-clinicaloverview.pdf
Size: 532 KB
Format: application/pdf

SpyGlass DS II Clinical Application Guide

PDF clinical overview of SpyGlass DS II Direct Visualization System containing recent clinical resources and papers by topic.

Download the SpyGlass DS II Clinical Data Overview to review recent clinical papers and key data about how the SpyGlass system can have a impact on biliary stone and stricture procedures.

Filename: cholangioscopy-clinical-data-reference-guide.pdf
Size: 579 KB
Format: application/pdf

SpyGlass DS II Clinical Data Overview

Connect with your rep

Questions about how cholangioscopy can help in your next ERCP?

Let's talk

1. Results from a comparative study where the pooled sensitivity and specificity of brushings for the diagnosis of malignant biliary strictures was 45% (95% confidence interval [CI], 40%–50%) and 99% (95% CI, 98%–100%), respectively* demonstrated in Navaneethan U, Zhu X, Lourdusamy D, Lourdusamy V, Vardarajulu S. Sa1378 Comparative effectiveness of various ERCP based modalities for detection of malignant biliary strictures. Gastrointest Endosc. 2017;85(Suppl 5): AB216–AB217.

2. Brewer Gutierrez, Olaya I. et al. Efficacy and Safety of Digital Single-Operator Cholangioscopy for Difficult Biliary Stones. Clinical Gastroenterology and Hepatology, Volume 16, Issue 6, 918 - 926.e1.

3. Almadi MA, Itoi T, Moon JH, et al. Using single-operator cholangioscopy for endoscopic evaluation of indeterminate biliary strictures: results from a large multinational registry. Clinical Study. Endoscopy. 2020;52:574–582.

*Results from different clinical investigations are not directly comparable. Information provided for educational purposes only.

Indications, Safety, and Warnings for SpyScope™ DS II

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

My account